Food allergy is a prevalent disorder associated with significant morbidity and mortality. There are currently no effective preventive measures or cures and tools for diagnosis are imperfect. This situation calls for innovative strategies to precisely define the molecular and cellular pathways in food allergy both so that novel diagnostic markers predicting risk of allergic reaction can be identified and so that new candidate targets for therapy can be identified. The known associations of several atopic conditions with activating polymorphisms in components of IL-4/13 receptors, along with our preliminary observation of intense food anaphylaxis in mice harboring an activating variant of IL-4R , provide support for our central hypothesis: that IL-4 signaling is critical in food anaphylaxi, driving TH2 responses, mast cell expansion and suppression of Treg. F709 mice, in which the inhibitory cytosolic ITIM motif of IL-4R is disrupted, will be used to test the hypothesis. Unliketheir wild-type Y709 counterparts which are tolerant to dietary antigens, they develop robust IgE responses to ingested proteins, intestinal mast cell expansion and full-blown anaphylactic reactions upon enteral challenge. This phenotype is unique among murine food allergy models, closely mimicking food allergy in humans. The F709 system provides a powerful resource both for focused analysis of direct IL-4 effects on mast cells T cells and intestinal epithelium and forprobing the interactions between mast cells, IgE antibodies, TH2 and Treg cells in the development of food allergy. Our hypothesis will be tested with the following aims:
AIM 1 : To define effects of enhanced IL-4 signaling on mast cell responsiveness, protease phenotype, gene expression and homeostasis in food allergy and to test IL-4R effects on target tissue sensitivity to mediators and on intestinal permeability AIM 2: To test mast cell and IgE antibody effects on immune sensitization (humoral and TH2responses) and on regulatory T cell (Treg) induction in F709 mice AIM 3: To examine the effects of pharmacologic mast cell inhibition or IgE blockade on immune sensitization to food allergens and on regulation of established responses Anticipated outcome: By defining specific alterations in mechanisms of mast cell, T cell, target tissue and gut epithelial functions in food allergen responses occurring in the settin of enhanced IL-4 signals, these studies will establish the critical factors, in addition to specifi IgE production, that place individuals at risk for food anaphylaxis. This has the potential to leadto both novel diagnostic markers for food allergy and to the identification of candidate targets fo therapy in established food allergy.

Public Health Relevance

Food allergy has become a major health issues in developed countries with an estimated prevalence of up to 6% in children and 3% in the adult population. It is difficult to elicit immune responses to ingested substances making studies of food allergy in animal models a challenge. In this proposal novel strain of mice, IL-4R? Y709F, highly susceptible to developing immune responses to foods, will be used to study mechanisms of food allergy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
High Priority, Short Term Project Award (R56)
Project #
1R56AI100889-01
Application #
8484555
Study Section
Hypersensitivity, Autoimmune, and Immune-mediated Diseases Study Section (HAI)
Program Officer
Davidson, Wendy F
Project Start
2012-07-01
Project End
2014-06-30
Budget Start
2012-07-01
Budget End
2014-06-30
Support Year
1
Fiscal Year
2012
Total Cost
$290,000
Indirect Cost
$123,333
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Noval Rivas, Magali; Burton, Oliver T; Wise, Petra et al. (2015) Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy. Immunity 42:512-23
Burton, Oliver T; Noval Rivas, Magali; Zhou, Joseph S et al. (2014) Immunoglobulin E signal inhibition during allergen ingestion leads to reversal of established food allergy and induction of regulatory T cells. Immunity 41:141-51
Burton, Oliver T; Logsdon, Stephanie L; Zhou, Joseph S et al. (2014) Oral immunotherapy induces IgG antibodies that act through Fc?RIIb to suppress IgE-mediated hypersensitivity. J Allergy Clin Immunol 134:1310-1317.e6
Oyoshi, Michiko K; Oettgen, Hans C; Chatila, Talal A et al. (2014) Food allergy: Insights into etiology, prevention, and treatment provided by murine models. J Allergy Clin Immunol 133:309-17
Zhou, Joseph S; Sandomenico, Annamaria; Severino, Valeria et al. (2013) An IgE receptor mimetic peptide (PepE) protects mice from IgE mediated anaphylaxis. Mol Biosyst 9:2853-9
Bartnikas, Lisa M; Gurish, Michael F; Burton, Oliver T et al. (2013) Epicutaneous sensitization results in IgE-dependent intestinal mast cell expansion and food-induced anaphylaxis. J Allergy Clin Immunol 131:451-60.e1-6
Burton, O T; Darling, A R; Zhou, J S et al. (2013) Direct effects of IL-4 on mast cells drive their intestinal expansion and increase susceptibility to anaphylaxis in a murine model of food allergy. Mucosal Immunol 6:740-50
Noval Rivas, Magali; Burton, Oliver T; Wise, Petra et al. (2013) A microbiota signature associated with experimental food allergy promotes allergic sensitization and anaphylaxis. J Allergy Clin Immunol 131:201-12